Biological pathway‐based Alzheimer’s Disease polygenic risk score and proteinopathy

Yuriko Katsumata, Xian Wu, Khine Zin Aung, Inori Tsuchiya, Lincoln MP Shade, Shama D Karanth, Kathryn Gauthreaux, Charles Mock, Walter A Kukull, Erin L Abner, Peter T Nelson, David W Fardo · 2025

Read Biological pathway‐based Alzheimer’s Disease polygenic risk score and proteinopathy by Yuriko Katsumata, Xian Wu, Khine Zin Aung, Inori Tsuchiya, Lincoln MP Shade, Shama D Karanth, Kathryn Gauthreaux, Charles Mock, Walter A Kukull, Erin L Abner, Peter T Nelson, David W Fardo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709564.txt.

Description

Yuriko Katsumata and co-authors built gene risk scores for Alzheimer's disease split by biological pathway in a 2025 study. A polygenic risk score adds up many small genetic effects into one number. A single total score, though, mixes pathways that may drive different kinds of brain damage.

The team had earlier tied genes to three protein problems seen in dementia brains: TDP-43, amyloid with tau, and alpha-synuclein. They built latent measures for each and formed pathway-specific scores. Such scores can test which pathway a person's genes push hardest. That split could sharpen trial design, matching patients to drugs by the biology their genes favor, rather than by symptoms alone.

Catalog record

CREATORYuriko Katsumata, Xian Wu, Khine Zin Aung, Inori Tsuchiya, Lincoln MP Shade, Shama D Karanth, Kathryn Gauthreaux, Charles Mock, Walter A Kukull, Erin L Abner, Peter T Nelson, David W Fardo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11709564

Browse the full library · About the Tower of Babel